Who has invested in Emendo Biotherapeutics?

AnGes Inc. are named among the investors backing Emendo Biotherapeutics.

Emendo Biotherapeutics Funding: $73M Raised, Series B (2020)

Emendo Biotherapeutics funding overview

Emendo Biotherapeutics is based in New York. Emendo Biotherapeutics has raised $73M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in January 2020. The round record for Emendo Biotherapeutics runs through 2020; nothing later has been disclosed. Investors on record include AnGes Inc..

Emendo Biotherapeutics at a glance

Total raised: $73M
Latest round: Series B
Latest round date: January 2020
Headquarters: New York
Notable investors: AnGes Inc.

Frequently asked about Emendo Biotherapeutics funding

How much has Emendo Biotherapeutics raised?: Emendo Biotherapeutics has raised $73M in total disclosed funding across the rounds on record.
Who has invested in Emendo Biotherapeutics?: AnGes Inc. are named among the investors backing Emendo Biotherapeutics.
What was the latest Emendo Biotherapeutics funding round?: The most recent disclosed round is a Series B, announced in January 2020.
Where is Emendo Biotherapeutics based?: Emendo Biotherapeutics is based in New York.
When did Emendo Biotherapeutics last raise?: The last disclosed Emendo Biotherapeutics round closed in January 2020 at Series B.

Every Emendo Biotherapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in New York at a similar stage.

Emendo Biotherapeutics Funding: $73M Raised, Series B (2020)

Emendo Biotherapeutics funding overview

Emendo Biotherapeutics at a glance

Frequently asked about Emendo Biotherapeutics funding

Companies related to Emendo Biotherapeutics (18)

Browse related funding lists (5)